AECOM shareholder plans sale of 9,502 shares after RSU vesting

AECOM had an individual named David Gan file a notice to sell 9,502 common shares, with an aggregate market value of $921,789.02, through Merrill Lynch on the NYSE around December 17, 2025.

Accepted by SEC EDGAR 12/17/2025 - 04:01 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

AECOM had an individual named David Gan file a notice to sell 9,502 common shares, with an aggregate market value of $921,789.02, through Merrill Lynch on the NYSE around December 17, 2025.

The shares to be sold come from restricted stock units and performance stock units that vested on December 15, 2025, in amounts of 2,875 and 6,627 shares, granted as compensatory awards by AECOM. During the prior three months, he also sold 6,000 AECOM common shares on December 15, 2025, generating gross proceeds of $593,100.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does AECOM (ACM) disclose in this Form 144 filing?

The filing states that an individual named David Gan plans to sell 9,502 AECOM common shares on the NYSE through Merrill Lynch, with an aggregate market value of $921,789.02.

How many AECOM (ACM) shares are planned to be sold and when?

The notice covers the proposed sale of 9,502 common shares of AECOM, with an approximate sale date of December 17, 2025 on the NYSE.

How did the seller acquire the AECOM (ACM) shares being sold?

The 9,502 shares come from AECOM equity awards that vested on December 15, 2025: 2,875 from a restricted stock unit vest and 6,627 from a performance stock unit vest, both described as compensatory payment from AECOM.

What recent AECOM (ACM) share sales has the filer made?

In the past three months, the filing reports that David Gan sold 6,000 AECOM common shares on December 15, 2025, for gross proceeds of $593,100.

How many AECOM (ACM) shares are outstanding according to the filing?

The document lists 131,833,332 AECOM common shares outstanding in connection with the planned sale described in the notice.

Which broker and exchange are involved in the planned AECOM (ACM) share sale?

The planned sale will be executed through Merrill Lynch at its Atlanta, Georgia office, with trading to occur on the New York Stock Exchange (NYSE).

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001805823
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	AECOM
SEC File Number	000-52423
Address of Issuer	13355 Noel Road DALLAS TEXAS 75240
Phone	972-788-1000
Name of Person for Whose Account the Securities are To Be Sold	DAVID GAN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	OFFICER

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	MERRILL LYNCH 3455 PEACHTREE RD NE STE 1000 ATLANTA GA 30326	9502	921789.02	131833332	12/17/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	12/15/2025	RESTRICTED STOCK UNIT VEST	AECOM			2875	12/15/2025	COMPENSATORY PAYMENT
COMMON	12/15/2025	PERFORMANCE STOCK UNIT VEST	AECOM			6627	12/15/2025	COMPENSATORY PAYMENT

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
DAVID GAN 13355 NOEL ROAD DALLAS TX 75240	COMMON	12/15/2025	6000	593100

144: Remarks and Signature

Remarks
Date of Notice	12/17/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/14/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	DAVID GAN
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)